Anupam Rasayan India Ltd Stock Analysis

BSE: 543275 | NSE: ANURAS | Chemicals | Mid Cap

BSE Share Price 23-Sep-2022 18:01
770.05 -14.45 (-1.84%)

DeciZen - Make an Informed Decision on Anupam Rasayan India

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Anupam Rasayan India Price Chart

P/E Ratio (SA) :
Market Cap :
7,722.6 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Anupam Rasayan India Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Anupam Rasayan India Ltd is a average quality company.

2. Is Anupam Rasayan India Ltd undervalued or overvalued?

The key valuation ratios of Anupam Rasayan India Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Anupam Rasayan India Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Anupam Rasayan India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Anupam Rasayan India:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Anupam Rasayan India Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 20.2%20.7%19.6%17.1%9.7%6.9%6.5%6.9%6.5%7.6%-
Value Creation Index

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1492282722882883435025298111,0661,139
YoY Gr. Rt. %-52.5%19.6%5.9%0%18.9%46.3%5.5%53.3%31.5%-
Adj EPS 1117.
YoY Gr. Rt. %-62.8%-62.7%29.1%-22.4%19.6%24.3%14.2%-45.4%139.3%-
BVPS (₹) 52.871.221.529.548.886.396.4113157.3171.6175.4
Adj Net Profit 1117.833.34333.439.949.656.661.9149156
Cash Flow from Ops. 20.15168.568.817.1-20.542.494.80.9-171-
Debt/CF from Ops.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 24.4%29.9%28.6%31.5%
Adj EPS 3.4%17.3%14.3%139.3%
BVPS 1428.621.29.1
Share Price - - - 1.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 23.228.837.233.716.811.310.310.35.799
Op. Profit Mgn % 25.221.524.927.924.421.818.625.423.827.828.9
Net Profit Mgn % 7.37.812.214.911.611.69.910.77.613.913.7
Debt to Equity
Working Cap Days 2001471401552273022913493183660
Cash Conv. Cycle 124845350841231521731602230

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 9.00%

Sales growth is growing at healthy rate in last 3 years 28.58%

Net Profit is growing at healthy rate in last 3 years 14.29%

Debt to equity has declined versus last 3 years average to 0.46

Sales growth is good in last 4 quarters at 26.45%

No data to display

Latest Financials - Anupam Rasayan India Ltd.

Standalone Consolidated
TTM EPS (₹) 15.6 15.9
TTM Sales (₹ Cr.) 1,139 1,139
BVPS (₹.) 175.4 175.6
Reserves (₹ Cr.) 1,659 1,661
P/BV 4.39 4.39
PE 49.44 48.34
From the Market
52 Week Low / High (₹) 547.10 / 1106.00
All Time Low / High (₹) 472.25 / 1106.00
Market Cap (₹ Cr.) 7,723
Equity (₹ Cr.) 100.3
Face Value (₹) 10
Industry PE 37.3

Management X-Ray of Anupam Rasayan India :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Anupam Rasayan India

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


About Anupam Rasayan India Ltd

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India. It commenced business as a partnership firm in 1984 as a manufacturer of conventional products and has, over the years, evolved into custom synthesis and manufacturing of life science related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and complex technologies, for a diverse base of Indian and global customers. Its key focus in its custom synthesis and manufacturing operations is developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.

Business area of the company

The company has two distinct business verticals (i) life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and (ii) other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.

Awards and Accreditations

  • 2016: Awarded ‘Green Innovation Award’ by Corning Reactor Technology for the year 2015.

Major events and milestones

  • 1984: The company was initially formed as a partnership firm as ‘Anupam Rasayan’ to commence the business of manufacture and sale of chemicals.
  • 2003: The partnership firm was converted into a joint stock company and was registered as a public limited company under the Companies Act 1956 under the name of ‘Anupam Rasayan India Limited’.
  • 2010: Started supplying specialty chemicals to Syngenta Asia Pacific Pte Ltd in Singapore.
  • 2014; Purchased the entire lease hold rights over the property and manufacturing facility at Jhagadia, Gujarat from Krishna Solvechem pursuant to a Deed of Conveyance  dated August 13, 2014 and an Asset Transfer Agreement dated May 16, 2014 respectively.
  • 2015: Received consent to establish for setting up industrial plant at Jhagadia Unit-5 from GPCB.
  • 2016: KPI LLC made its first tranche of investment in company.
  • 2017: Commenced supply of speciality chemicals to Sumitomo Chemical Company in Japan.
  • 2018: KPI LLC invested $35 million as an external commercial borrowing in company.
  • 2019: Received consolidated consents and authorisation for Jhagadia Unit - 5 and Sachin Unit-6, both from GPCB.
  • 2020: Received consolidated consent and authorisation for the research and development centre on Sachin Unit-6 from GPCB.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now